Lindbrook Capital »

Allogene Therapeutics shares owned by Lindbrook Capital

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Lindbrook Capital from 13F filings

Historical chart of Lindbrook Capital investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Lindbrook Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Lindbrook Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $5.6k 1.2k 4.47
2023-12-31 $5.1k 1.6k 3.21
2023-09-30 $2.1k 648 3.17
2023-06-30 $6.8k 1.4k 4.97
2023-03-31 $8.5k 1.7k 4.94
2022-12-31 $0 0 0.00
2022-09-30 $5.0k 418 11.96
2022-06-30 $5.0k 436 11.47
2022-03-31 $999 110 9.09